Concordance of Capillary Blood Biological Samples With Conventional Venousbiological Blood Samples.
NCT ID: NCT03890146
Last Updated: 2021-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
1 participants
OBSERVATIONAL
2018-12-20
2020-12-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
To Validate an Analytical Method to Measure Concentration of Tacrolimus in Blood Taken From Finger Pricks
NCT02377609
Clinical Study Evaluating Safety of a New Catheter for Urinary Intermittent Catheter in Healthy Volunteers
NCT01292941
Distribution of Biospecimens From Biorepositories/Biobanks for Research Use
NCT03884400
Evaluation of the CloSys Closure System as an Adjunct to Standard Compression
NCT00963690
A Multi-Center Protocol for Obtaining and Storing Human Samples for Immediate or Future Microbial, Immune, or Host Microbe Scientific Study
NCT00765141
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Medical prescription
* The pre-analytic phase (preparation of the material, completion of the sample, transport of the sample and preparation of it)
* The analytical phase
* The post-analytic phase (validation of the result obtained and the dissemination of it to the prescriber, usually the clinician, who is then able to make a medical decision) This succession of steps involves, as part of a classical journey, many stakeholders (doctors, nurses, couriers, laboratory technicians, medical biologists) in different places.
Outsourced biology (care test point, POCT) refers to the analysis of biological samples outside the central laboratory. The sample is most often carried out, transported and analyzed by the same person on a machine near the patient or in the service and therefore in the absence of direct control of a specialized laboratory technician or a medical biologist, who remains however responsible for good practice, maintenance of the device and validity of the results.
The completion of biological examinations is regulated by differents Articles. The outsourced biology (ADBD) sampling analysis can be carried out in the hospital, in most departments, and also outside the hospital (pharmacies, city offices or even in the patient's own home). On portable devices, usually highly specialized, and these fixed allowing a greater diversity of tests.
Its development is booming with annual growth estimated in 2006 at 15.5% in the United States.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intensive care patients
patient hospitalised in intensive care unit veinous and capillary ponction
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Affiliate or beneficiary of a social security scheme
* Express consent to participate in the study
Exclusion Criteria
* Patient not communicating
* Pregnant or breastfeeding woman
* Peripheral edema (taking more than 5 Kg since entering the service)
* Patient in shock (mean arterial pressure \< 65 mmHg or continuous catecholamine administration)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondation Ophtalmologique Adolphe de Rothschild
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nefeli Nasika
Role: PRINCIPAL_INVESTIGATOR
Fonadtion Afolphe Rothschild
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
France
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A01880-55
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.